Details for New Drug Application (NDA): 210004
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 210004
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Taro |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210004
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 210004
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 210004 | ANDA | Taro Pharmaceuticals U.S.A., Inc. | 51672-4194 | 51672-4194-3 | 1 CAN in 1 CARTON (51672-4194-3) / 50 g in 1 CAN |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 210004 | ANDA | Taro Pharmaceuticals U.S.A., Inc. | 51672-4194 | 51672-4194-7 | 1 CAN in 1 CARTON (51672-4194-7) / 100 g in 1 CAN |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 1% | ||||
Approval Date: | Mar 11, 2020 | TE: | AT | RLD: | No |
Complete Access Available with Subscription